26 reports

  • MARKET SIZE: GLOBAL LUNG CANCER LIQUID BIOPSY MARKET
  • Identifying factors that impede market growth

About Lung Cancer Liquid Biopsy A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It...

  • Biopsy
  • Cancer
  • Lung Cancer
  • Biocept, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Market size: Global prostate cancer testing market
  • MARKET SIZING 2017

About Prostate Cancer Testing Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal...

  • Cancer
  • Prostate Cancer
  • World
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA
  • GROWING APPROVALS IN LUNG CANCER THERAPEUTICS MARKET

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes...

  • Cancer
  • Lung Cancer
  • Therapy
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.

With the number of Canadians aged ## and older expected to grow by 2030 -- moving from one in eight now, to one in four -- the face of cancer will change.

  • Cancer
  • Cancer Diagnostic
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Vendor landscape
  • Geographical segmentation

You can easily book an appointment with one online.

  • Cancer
  • United States
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly
  • Vendor landscape

PART ##: Disease overview TYPES OF GASTRIC CANCER Gastric cancer is one of the common types of cancer.

  • Cancer
  • Gastric Cancer
  • Therapy
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Global HER-2 Positive Breast Cancer Market
  • 08.3 HER-2 POSITIVE BREAST CANCER MARKET IN US

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

  • Cancer
  • United States
  • World
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • 05. Introduction
  • 19.1 Competitive Scenario

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal...

  • Cancer
  • United States
  • World
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • Identifying factors impacting market growth
  • Market sizing 2017

About Tissue Diagnostics Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH) Technavio’s analysts forecast the Global Tissue diagnostics Market to grow at a CAGR of 10.22%...

  • Cancer
  • World
  • Forecast
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • PANCREATIC CANCER THERAPEUTICS, GLOBAL, DEVELOPMENTAL PIPELINE, PHASE I, 2015
  • 8.1 All Pipeline Drugs by Phase

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Summary Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates rapidly, is...

  • Cancer
  • Clinical Trial
  • Pancreatic Cancer
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • Global cervical cancer market
  • Global pancreatic cancer drugs market

About the Solid Tumors Drugs Market The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors. Solid tumors are an abnormal mass of tissue that do not contain cysts...

  • Breast Cancer
  • Cancer
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Executive Summary

ABOUT ## IN ## CASES OF THIS CANCER ARE HER## POSITIVE.

  • Cancer
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Global Kidney Cancer Drugs Market
  • 19.1 COMPETITIVE SCENARIO

About Kidney Cancer Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease is not yet known. The symptoms of renal cancer are often confused with other kidney disorders. This usually results in late stage detection...

  • Cancer
  • Renal Cancer
  • Therapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET
  • F. HOFFMANN-LA ROCHE: YOY GROWTH AND REVENUE GENERATED FROM NET PRODUCT SALES OF AVASTIN 2011-2014 ($ BILLIONS)

About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs...

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • 06.2 PATHOPHYSIOLOGY
  • 07.1 MARKET OVERVIEW

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

  • Breast Cancer
  • Cancer
  • Therapy
  • Market Segment
  • F. Hoffmann-La Roche Ltd.

According to OECD (2015), one in ## women acquires breast cancer in their lifetime.

  • Cancer
  • Sexually Transmitted Disease
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.

You can easily book an appointment with one online.

  • Cancer
  • United States
  • Forecast
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* Stage of Development

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Amgen Inc. ## ## ## ## ## ## ## ## AbbVie Inc. ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2015 2015 trials are taken as of Augu

  • Cancer
  • Clinical Trial
  • Hospital
  • Lymphoma
  • F. Hoffmann-La Roche Ltd.
  • TOP COMPANIES PARTICIPATING IN METASTATIC BREAST CANCER THERAPEUTICS CLINICAL TRIALS
  • As of December 2017, F. Hoffmann-La Roche Ltd sponsored the highest number of metastatic breast cancer clinical trials.

Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Breast Cancer clinical trials scenario. This report provides top line data relating to...

  • Breast Cancer
  • Cancer
  • Chemotherapy
  • Clinical Trial
  • F. Hoffmann-La Roche Ltd.
  • 18.1 Competitive Scenario
  • 18.2 Market Share Analysis 2014

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Brain Cancer
  • Cancer
  • Therapy
  • Market Size
  • F. Hoffmann-La Roche Ltd.
  • Clinical Trial Profiles
  • LOCATION(S)/SPONSOR(S) SPONSOR(S)/COLLABORATOR(S) - TYPE & DETAILS

Bevacizumab (RG##) is under development for the treatment of fallopian ovarian cancer, epethelial ovarian cancer and peritoneal cancer, intracranial meningioma, locally advanced/ metastatic well-differentiated digestive endocrine tumors, relapsed or refractory neurobl

  • Cancer
  • Clinical Trial
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • Threshold
  • Children's Cancer and Leukaemia Group and F. Hoffmann-La Roche Ltd have conducted highest number of ependymoma clinical trials.
  • As of August 2017, Children's Cancer and Leukaemia Group and F. Hoffmann-La Roche Ltd sponsored the highest number of ependymoma clinical trials.

Ependymoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Ependymoma Global Clinical Trials Review, H2, 2017" provides an overview of Ependymoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ependymoma. Report includes an overview...

  • Brain Cancer
  • Cancer
  • Pathology
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • 5. All the trials included are unique trials.

Induction included oral lenalidomide ## mg/ day, days ##-## per ##-day cycle (d##- ##/ ##) plus intravenous rituximab ## mg/ m##, days ##, ##, ##, and ## of cycle ## and day ## of cycles ##, ##, ##, ##, and ## (##-day cycles).

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • World
  • F. Hoffmann-La Roche Ltd.
  • 5. All the trials included are unique trials.

(TORG##) A Phase II Study Of Erlotinib/ S-## Combination Therapy In Patients with Recurrent Or Advanced Non-small Lung Cancer Who Do Not Possess Active Egfr Mutation.

  • Cancer
  • Clinical Trial
  • Respiratory Disease
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • Clinical Trial profile. 80 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • Leukemia
  • Monoclonal Antibody
  • F. Hoffmann-La Roche Ltd.

The prominent features of this report are - ##.

  • Cancer
  • Therapy
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.